Combination of fractionated irradiation with nicotinamide and carbogen in R1H-tumours of the rat and its pulmonary metastases

Radiotherapy and Oncology

Volumn 45, Issue 2, 1997, Pages 183-189

  Raabe, Annette ^a   Rett, Manuel ^a   Krüll, Andreas ^a   Beck Bornholdt, Hans Peter ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Carbogen; Irradiation; Lung; Metastases; Nicotinamide; Tumour

Indexed keywords

CARBOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RADIOTHERAPY; DOSE RESPONSE; FEMALE; LUNG METASTASIS; METASTASIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIZATION; RAT; SKIN TUMOR; TREATMENT OUTCOME;

ANIMALS; CARBON DIOXIDE; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LUNG; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, EXPERIMENTAL; NIACINAMIDE; OXYGEN; RADIATION-SENSITIZING AGENTS; RATS; RHABDOMYOSARCOMA; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0031282092     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)00152-7     Document Type: Article

References (47)

1. [1] Beck-Bornholdt, H.-P., Würschmidt, F. and Vogler, H. Net growth delay: a novel parameter derived from tumour growth curves. Int. J. Radiat. Oncol. Biol. Phys. 13: 773-777, 1987.
2. [2] Beck-Bornholdt, H.-P. and Dubben, H.-H. Potential pitfalls in the use of p-values and in interpretation of significance levels. Radiother. Oncol. 33: 171-176, 1994.
3. [3] Bentzen, S.M., Vaeth, M., Pedersen, D.E. and Overgaard, J. Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment... now! Int. J. Radiat. Oncol. Biol. Phys. 32: 1531-1534, 1995.
4. [4] Caplan, R.J., Pajak, T.F. and Cox, J.D. Analysis of the probability and risk of cause-specific failure. Int. J. Radiat. Oncol. Biol. Phys. 29: 1183-1186, 1994.
5. [5] Caplan, R.J., Pajak, T.F. and Cox, J.D. In response to Bentzen et al. Int. J. Radiat. Oncol. Biol. Phys. 32: 1547, 1995.
6. [6] Chaplin, D.J., Horsman, M.R. and Aoki, D. Nicotinamide, fluosol DA and carbogen: strategy to reoxygenate acutely and chronically hypoxic cells in vivo. Br. J. Cancer 63: 109-113, 1991.
7. [7] Chaplin, D.J., Horsman, M.R. and Siemann, D.W. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time. Br. J. Cancer 68: 269-273, 1993.
8. [8] Chapman, J.D. Measurements of tumour hypoxia by invasive and non-invasive procedures: a review of recent clinical studies. Radiother. Oncol. 20 (Suppl.): 13-19, 1991.
9. [9] Dische, S., Rojas, A., Rugg, T., Hong, A. and Michael, B.D. Carbogen breathing: a system for use in man. Br. J. Radiol. 65: 87-90, 1992.
10. [10] Fatigante, L., Ducci, F., Cartei, F., Colosimo, S., Marini, C., Preditetto, R., Danesi, R., Laddage, M., del Tacca, M. and Caciagli, P. Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new treatment modality. Int. J. Radiat. Oncol. Biol. Phys. 37: 499-504, 1997.
11. [11] Haustermans, K., van der Kogel, A.J., Vanacker, B. and van der Schueren, E. Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation tolerance. Radiother. Oncol. 31: 123-128, 1394.
12. [12] Henk, J.M. Late results of a clinical trial of hyperbaric oxygen and radiotherapy in head and neck cancer: a rationale for hypoxic cell sensitisers? Int. J. Radiat. Oncol. Biol. Phys. 2: 1339-1341, 1986.
13. [13] Höckel, M., Schlenger, K., Aral, B., Vorndran, B., Mitze, M., Schäffer, U. and Vaupel, P. Association between tumour hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res., 56: 4509-4515, 1996.
14. [14] Horsman, M.R., Chaplin, D.J. and Brown, M. Radiosensitization by nicotinamide in vivo: a greater enhancement of tumour damage compared to that of normal tissues. Radiat. Res. 109: 479-489, 1987.
15. [15] Horsman, M.R., Hansen, P.V. and Overgaard, J. Radiosensitization by nicotinamide in tumours and normal tissues: the importance of tissue oxygenation status. Int. J. Radiat. Oncol. Biol. Phys. 16: 1273-1276, 1989.
16. [16] Horsman, M.R., Chaplin, D.J. and Brown, M. Tumour radiosensitization by nicotinamide: a result of improved perfusion and oxygenation. Radiat. Res. 118: 139-150, 1989.
17. [17] Horsman, M.R. Nicotinamide and the hypoxia problem. Radiother. Oncol. 22: 79-80, 1991.
18. [18] Horsman, M. Tolerance to nicotinamide and carbogen with radiation therapy for glioblastoma. Radiother. Oncol. 13: 109-110, 1997.
19. [19] Hoskin, P.J., Stratford, M.R.L.S., Saunders, M.I., Hall, D.W., Dennis, M.F. and Rojas, A. Administration of nicotinamide during CHART: pharmacokinetics, dose escalation and clinical toxicity. Int. J. Radiat. Oncol. Biol. Phys. 32: 1111-1119, 1995.
20. [20] Jonsson, G.G., Kjellen, E., Pero, R.W. and Cameron, R. Radiosensitization effects of nicotinamide on malignant and normal mouse tissue. Cancer Res. 45: 3609-3614, 1985.
21. [21] Kaanders, J.H.A.M. and van der Maazen, R.W.M. A convenient method for carbogen breathing in man. Radiother. Oncol. 29: 341-343, 1993.
22. [22] Kaanders, J.H.A.M., Pop, L.A.M., Marres, H.A.M., van der Maazen, R.W.M., van der Kogel, A.J. and van der Daal, W.A.J. Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity. Radiother. Oncol. 37: 190-198, 1995.
23. [23] Kaplan, E.L. and Meier, P. Non-parametric estimation from incomplete observation. J. Am. Stat. Assoc. 53: 457-481, 1958.
24. [24] Kelleher, D.K. and Vaupel, P.W. Possible mechanisms involved in tumor radiosensitization following nicotinamide administration. Radiother. Oncol. 32: 47-53, 1994.
25. [25] Kjellen, E., Pero, R.W. and Nilsson, P. Comparison of low dose nicotinamide versus benzamide, administered per os, as radiosensitizers in a C3H mammary carcinoma. Radiother. Oncol. 12: 327-331, 1988.
26. [26] Kjellen, E., Joiner, M.C., Collier, J.M., Johns, H. and Rojas, A. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Radiother. Oncol. 22: 81-91, 1991.
27. [27] Lee, I., Boucher, Y. and Jain, R.K. Nicotinamide can lower tumour interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res. 52: 3237-3240, 1992.
28. [28] Lee, I. and Song, C.W. The oxygenation of murine tumour isografts and human xenografts by nicotinamide. Radiat. Res. 130: 65-71, 1992.
29. [29] Moulder, J.E. and Rockwell, S. Hypoxic fractions of solid tumours: experimental techniques, methods of analysis, and a survey of existing data. Int. J. Radiat. Oncol. Biol. Phys. 10: 695-712, 1984.
30. [30] Nordsmark, M., Overgaard, M. and Overgaard, J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41: 31-39, 1996.
31. [31] Pickles, T., Graham, P., Syndikus, I., Rheaume, I., Duncan, G.G., Green, A. and Marlow, C. Tolerance of nicotinamide and carbogen with radiation therapy for glioblastoma. Radiother. Oncol. 40: 245-247, 1996.
32. [32] Pigott, K., Dische, S. and Saunders, M.I. The addition of carbogen and nicotinamide to a palliative fractionation schedule for locally advanced breast cancer. Br. J. Radiol. 68: 215-218, 1995.
33. [33] Raabe, A. Wachstumskinetik und Strahlenempfindlichkeit pulmonaler Mikrometastasen des Rhabdomyosarkoms R1H der Ratte. Thesis, University of Hamburg, 1991.
34. [34] Raabe, A. and Beck-Bornholdt, H.-P. Radiobiological determination of growth kinetics and radiosensitivity of pulmonary micrometastases of the R1H-tumour. Radiother. Oncol. 30: 254-262, 1994.
35. [35] Rockwell, S. and Moulder, J.E. Hypoxic fractions of human tumors xenografted into mice: a review. Int. J. Radiat. Oncol. Biol. Phys. 19: 197-202, 1990.
36. [36] Rojas, A. Radiosensitization with normobaric oxygen and carbogen. Radiother. Oncol. 20: 65-70, 1991.
37. [37] Rojas, A., Hodgkiss, R.J., Stratford, M.R.L., Dennis, M.F. and Johns, H. Pharmocokinetics of varying doses of nicotinamide and tumour radiosensitization with carbogen and nicotinamide: clinical considerations. Br. J. Radiol. 68: 1115-1121, 1993.
38. [38] Rojas, A., Hirst, V,K., Calvert, A. and Johns, H. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 34: 357-365, 1996.
39. [39] Rojas, A., Vojnovic, B., Johns, H., Joiner, M.C., Martindale, C., Fowler, J.F. and Denekamp, J. Radiosensitisation in normal tissues with oxygen, carbogen of nicotinamide: therapeutic gain comparison for fractionated x-ray schedules. Radiother. Oncol. 39: 53-64, 1996.
40. [40] Van der Maazen, R.W.M., Thijssen, H.O.M., Kaanders, J.H.A.M., de Koster, A., Keyser, A., Prick, M.J.J., Grotenhuis, J.A., Wesseling, P. and van der Kogel, A.J. Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas. Radiother. Oncol. 35: 118-122, 1995.
41. [41] van der Kogel, A.J. and Sissingh, H.A. Effect of misonidazole on the tolerance of the rat spinal cord to daily and multiple fractions per day of X rays. Br. J. Radiol. 56: 121-125, 1983.
42. 2 tension measurements. Cancer Res. 51: 3316-3322, 1991.
43. [43] Vogler, H. and Beck-Bornholdt, H.-P. Radiobiology of the rhabdomyosarcoma R1H of the rat: kinetics of cellular inactivation by fractionated irradiation. Int. J. Radiat. Oncol. Biol. Phys. 14: 317-325, 1988.
44. [44] Würschmidt, F., Beck-Bornholdt, H.-P. and Vogler, H. Radiobiology of the rhabdomyosarcoma R1H of the rat: influence of the size of irradiation field on tumour response, tumour bed effect, and neovascularization. Int. J. Radiat. Oncol. Biol. Phys. 18: 879-882, 1990.
45. [45] Zackheim, H.S., Vasily, D.B., Westphal, M.L. and Hastings, C.W. Reactions to niacinamide. J. Am. Acad. Dermatol. 4: 736-737, 1981.
46. [46] Zackrisson, B., Franzen, L., Henriksson, R., Littbrand, B., Stratford, M., Dennis, M., Rojas, A. and Denekamp, J. Acute effects of accelerated radiotherapy in combination with carbogen and nicotinamide (ARCON). Acta Oncol. 33: 377-381, 1994.
47. [47] Zywietz, F.M., Reeker, W. and Kochs, E. Tumor oxygenation in a transplanted rat rhabdomyosarcoma during fractionated irradiation. Int. J. Radiat. Oncol. Biol. Phys. 32: 1391-1400, 1995.